Mauna Kea Technologies S.A.
PAR: MKEA.PA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Alexandre Loiseau
- Employees
- 68
- Headquarters
- Paris, France
- IPO year
- 2011
- Market cap
- €30.2M
- Website
- https://www.maunakeatech.com
Loading MKEA…
Loading profile data…Frequently asked questions about MKEA
What does Mauna Kea Technologies S.A. (MKEA.PA) do?
Mauna Kea Technologies SA develops and markets medical devices in Europe, the Middle East, Africa, the United States, Latin America, and Asia. The company designs, develops, and markets tools to visualize and detect cell abnormalities in real time during standard gastrointestinal and pulmonary endoscopy procedures. Its flagship product is Cellvi...
Where does MKEA.PA trade?
Mauna Kea Technologies S.A. (MKEA.PA) trades on the Euronext Paris.
What sector is MKEA.PA in?
Mauna Kea Technologies S.A. (MKEA.PA) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Mauna Kea Technologies S.A.?
Alexandre Loiseau is the chief executive officer of Mauna Kea Technologies S.A. (MKEA.PA).
Where is Mauna Kea Technologies S.A. headquartered?
Mauna Kea Technologies S.A. is headquartered in France.
Does MKEA.PA pay a dividend?
Mauna Kea Technologies S.A. (MKEA.PA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MKEA.PA go public?
Mauna Kea Technologies S.A. (MKEA.PA) completed its initial public offering in 2011.